Test could help determine which patients respond to immunotherapies.
Regulator reviewing combination therapy safety after issue with Keytruda
BMS will gain rights to preclinical cancer immunotherapy drugs.
Partnerships, co-marketing and the positioning of drugs are shaping the competitive landscape in oncology.
Contrasting fortunes for Roche and AZ in a week of drama.
FDA to make decision on wider lung cancer use within a week.
AZ hopes for blockbuster sales from Imfinzi.
BI developing combinations with its own checkpoint inhibitors